Expression of the miR-17-92 polycistron in chronic myeloid leukemia (CML) CD34+ cells - Wikidata - awgldk - TriplyDB

Expression of the miR-17-92 polycistron in chronic myeloid leukemia (CML) CD34+ cells

Expression of the miR-17-92 polycistron in chronic myeloid leukemia (CML) CD34+ cells

http://www.wikidata.org/entity/Q28287105

about

"Myc'ed messages": myc induces transcription of E2F1 while inhibiting its translation via a microRNA polycistron Aberrant overexpression and function of the miR-17-92 cluster in MLL-rearranged acute leukemia The miR-17-92 microRNA polycistron regulates MLL leukemia stem cell potential by modulating p21 expression MiR-17-92 cluster is associated with 13q gain and c-myc expression during colorectal adenoma to adenocarcinoma progression The miR-17-5p microRNA is a key regulator of the G1/S phase cell cycle transition Chromosomal rearrangements and microRNAs: a new cancer link with clinical implications The Role of MicroRNAs in Myeloproliferative Neoplasia Clinical significance of microRNAs in chronic and acute human leukemia MicroRNAs mediated regulation of MAPK signaling pathways in chronic myeloid leukemia Epigenomics of leukemia: from mechanisms to therapeutic applications MicroRNAs: promising new antiangiogenic targets in cancer miRNAs as Biomarkers in Chronic Myelogenous Leukemia MicroRNA-92a controls angiogenesis and functional recovery of ischemic tissues in mice STAT3 upregulates miR-92a to inhibit RECK expression and to promote invasiveness of lung cancer cells Activation of miR-17-92 by NK-like homeodomain proteins suppresses apoptosis via reduction of E2F1 in T-cell acute lymphoblastic leukemia The proto-oncogene LRF is under post-transcriptional control of MiR-20a: implications for senescence miR-17* suppresses tumorigenicity of prostate cancer by inhibiting mitochondrial antioxidant enzymes BCR-ABL affects STAT5A and STAT5B differentially Expression and rhythmic modulation of circulating microRNAs targeting the clock gene Bmal1 in mice MicroRNAs in cancer.miR-328 functions as an RNA decoy to modulate hnRNP E2 regulation of mRNA translation in leukemic blasts.Downregulation of miR-31, miR-155, and miR-564 in chronic myeloid leukemia cells The Effects of Antisense miRNA-20a Alone or in Combination with Imatinib on K562 Cell Proliferation Circadian regulation of a limited set of conserved microRNAs in Drosophila.Cloning and characterization of microRNAs from rainbow trout (Oncorhynchus mykiss): their expression during early embryonic development.A novel and universal method for microRNA RT-qPCR data normalization.Analysis of microRNA transcriptome by deep sequencing of small RNA libraries of peripheral blood Identification of nuclear-enriched miRNAs during mouse granulopoiesis Non-coding RNAs: a key to future personalized molecular therapy?Clinical impact of down-regulated plasma miR-92a levels in non-Hodgkin's lymphoma Overexpression of microRNAs from the miR-17-92 paralog clusters in AIDS-related non-Hodgkin's lymphomas Nanopharmacology in translational hematology and oncology Chronic myeloid leukemia: mechanisms of blastic transformation Micro-RNA response to imatinib mesylate in patients with chronic myeloid leukemia The antileukemia activity of natural product HQ17(3) is possibly associated with downregulation of miR-17-92 cluster.Downregulated microRNA-148b in circulating PBMCs in chronic myeloid leukemia patients with undetectable minimal residual disease: a possible biomarker to discontinue imatinib safely.Circulating microRNA expression is associated with genetic subtype and survival of multiple myeloma.Lyn kinase-dependent regulation of miR181 and myeloid cell leukemia-1 expression: implications for drug resistance in myelogenous leukemia.BCR-ABL/GATA1/miR-138 mini circuitry contributes to the leukemogenesis of chronic myeloid leukemia.cMyc/miR-125b-5p signalling determines sensitivity to bortezomib in preclinical model of cutaneous T-cell lymphomas.

P2860

Q21145225-CA327B08-4154-41CC-8E84-037C14C0651E Q24624389-CCDAF96F-526D-4BCE-9EFF-B6A903838CC6 Q24630336-43C3DD11-D665-46A6-9E68-DC5DEC4D87C0 Q24643470-89292EF6-44BB-4531-AF36-346C803F4B42 Q24646324-8F32903F-A711-4972-9D0A-B0008C31CBF5 Q24683729-5568B20A-34C1-48D2-B015-9D7F85B18E4E Q26739435-2C36D824-06BF-430F-B592-EE7A49641B78 Q26749533-C3E02E2C-B87F-430B-8C00-08758FBF9EC2 Q26766288-FAFEB634-DCBB-4879-BFC0-457035E26DFD Q26823403-2C534823-E338-41C4-BC7B-B71EEB8DC8DB Q27027998-8795E1B0-A8DA-413C-930C-1B6DF830BFE9 Q28087081-07643DBA-E5E0-487C-A1ED-B2D6EDBA8D9E Q28115423-68B04783-0B18-4401-9FCF-A76D4B6B81D4 Q28118347-7F240E1B-C883-4989-9385-9CF144A5F6F6 Q28306913-FB165379-9C19-42B5-9D81-CE3ABB1B1051 Q28473050-CD6E2E8E-0765-468B-8093-163DA61025FB Q28476613-9590E5E0-8DFA-4466-BCF2-DFDB4A9B1C4D Q28538914-7473A40E-219B-4D78-BF59-F5BD055B3B0F Q28742256-70D548B8-4B6E-46DB-BBBC-E512F1D3421A Q30437444-AF1A16EF-6CCF-4B14-BC34-D8D749D456D7 Q30496174-43FA3E14-FA7B-4D7C-BDA3-25634218B558 Q31055456-73406D72-307E-4645-A84E-6D09D67B3304 Q32179310-325A9D91-0462-4D77-B6BE-AF6D3990F506 Q33320345-06C7B64C-FC29-4208-B407-132CF01227E7 Q33328334-2906B3AD-74F4-4B46-AA46-CD61EB5210F0 Q33468633-23A6FB19-2604-4082-A5D1-053F3ED65D4E Q33575211-30581E61-C39F-45B7-95E2-97B9AF01FEF4 Q33713584-3709E69C-2375-46FF-8F3F-B4B0C768961D Q33762263-30CBFB0A-F991-41ED-9DE8-62C0D9912243 Q33839512-06B9C9E7-AE3B-420E-8945-0DAC554DB7A4 Q33940931-4E7CF003-77F7-4BB4-9625-91D1BF47914F Q33961538-44133179-644B-4009-BB66-D8D770309979 Q33968037-82BE6A3C-4C05-4936-A8FE-360C81B0E8B6 Q34032219-7028D1F0-0C18-4B19-A921-8A25F4D55B7B Q34032950-C30CACE4-810C-49A5-917D-971BA3991ED4 Q34109784-572C8077-3AE4-49EF-8D3B-C2F4301BD99A Q34263619-AA0080AB-78A9-484D-987A-7EC1C21821BC Q34309928-274FF973-8012-4DE9-81E4-33116FF7C316 Q34315303-D6E2E95B-756A-4371-9AA3-B951175359DB Q34635116-4E151285-C8FF-4008-AF41-D4B80890C1FD

P2860

Expression of the miR-17-92 polycistron in chronic myeloid leukemia (CML) CD34+ cells

http://www.wikidata.org/entity/Q28287105

description

2007 nî lūn-bûn

@nan

2007 թուականի Մայիսին հրատարակուած գիտական յօդուած

@hyw

2007 թվականի մայիսին հրատարակված գիտական հոդված

@hy

2007年の論文

@ja

2007年論文

@yue

2007年論文

@zh-hant

2007年論文

@zh-hk

2007年論文

@zh-mo

2007年論文

@zh-tw

2007年论文

@wuu

name

Expression of the miR-17-92 polycistron in chronic myeloid leukemia (CML) CD34+ cells

@ast

Expression of the miR-17-92 polycistron in chronic myeloid leukemia (CML) CD34+ cells

@en

Expression of the miR-17-92 polycistron in chronic myeloid leukemia (CML) CD34+ cells

@nl

type

label

Expression of the miR-17-92 polycistron in chronic myeloid leukemia (CML) CD34+ cells

@ast

Expression of the miR-17-92 polycistron in chronic myeloid leukemia (CML) CD34+ cells

@en

Expression of the miR-17-92 polycistron in chronic myeloid leukemia (CML) CD34+ cells

@nl

prefLabel

Expression of the miR-17-92 polycistron in chronic myeloid leukemia (CML) CD34+ cells

@ast

Expression of the miR-17-92 polycistron in chronic myeloid leukemia (CML) CD34+ cells

@en

Expression of the miR-17-92 polycistron in chronic myeloid leukemia (CML) CD34+ cells

@nl

P1433

Q28287105-8A5CA0F8-10F7-4B7B-80D2-58AF0092CA4E

P1476

Q28287105-EEA6336C-3405-45AB-927E-D33E5D4704E0

P2093

Q28287105-3F96D16D-A1AD-4B74-82FB-83FA0B9D6151

Q28287105-54992C25-253A-4B20-87FE-B4686BE3D0CF

Q28287105-6E32BFD9-E7FD-4D64-966F-7983A96AE2BE

Q28287105-7F915BD1-E985-470F-BCB6-701D3BC829AF

Q28287105-89889665-385D-4DA1-9BAF-D49BF267B983

Q28287105-9C43C008-E8B5-4024-ADEC-59EA026BEB4E

Q28287105-DDF91C64-902A-44E8-9147-F5B2A5EEAD00

Q28287105-FBF5A850-1262-415E-B31D-222274B605BB

P304

Q28287105-1A8F6C79-520D-4857-886E-670A25FFF005

P31

Q28287105-37D89D0D-8119-4EDF-A837-A6568B7BD378

P3181

Q28287105-E7E88FF1-8205-4A64-B572-2E0CD8B3474C

P356

Q28287105-F8A0FE6F-D972-4102-BFB1-601E60356BCD

P407

Q28287105-DD6E897B-2704-4B42-9556-5BA08513D5E4

P433

Q28287105-44C6E37F-10F5-4064-BCD2-A7C45C56E165

P478

Q28287105-8C48578B-530F-412A-AEB1-CCF385E893ED

P50

Q28287105-D70CAF07-2376-4125-B2BD-DA3F63FCC5AD

P577

Q28287105-B355B7E5-8E6F-4972-90D6-B43ECB0440D0

P5875

Q28287105-D5F5AF3C-11DC-4845-8AAA-8E8CDBED69E9

P698

Q28287105-7F356738-66BC-4EED-ADDB-490F39EB7B1A

P921

Q28287105-046F7628-6EF4-4982-99E8-1FDCE4B4C579

Q28287105-278ACB79-66D5-495C-AA4F-53E80DE19AB5

P3181

P356

BLOOD-2006-09-045104

P1433

P1476

Expression of the miR-17-92 polycistron in chronic myeloid leukemia (CML) CD34+ cells

@en

P2093

Arnold Ganser

http://www.w3.org/2001/XMLSchema#string

Beate Schultheis

http://www.w3.org/2001/XMLSchema#string

Karin Battmer

http://www.w3.org/2001/XMLSchema#string

Letizia Venturini

http://www.w3.org/2001/XMLSchema#string

Martina U Muckenthaler

http://www.w3.org/2001/XMLSchema#string

Matthias Eder

http://www.w3.org/2001/XMLSchema#string

Michaela Scherr

http://www.w3.org/2001/XMLSchema#string

Mirco Castoldi

http://www.w3.org/2001/XMLSchema#string

P304

4399-405

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P3181

1634996

http://www.w3.org/2001/XMLSchema#string

P356

10.1182/BLOOD-2006-09-045104

http://www.w3.org/2001/XMLSchema#string

P407

P433

10

http://www.w3.org/2001/XMLSchema#string

P478

109

http://www.w3.org/2001/XMLSchema#string

P50

Andreas Hochhaus

P577

2007-05-15T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

6519315

http://www.w3.org/2001/XMLSchema#string

P698

17284533

http://www.w3.org/2001/XMLSchema#string

P921

chronic myeloid leukemia